Why shares in this ASX dairy producer are on watch today

Shares in Synlait Milk Ltd (ASX: SM1) are on watch today after the dairy producer released its half year results in the midst of market turmoil.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Synlait Milk Ltd (ASX: SM1) are on watch today after the Kiwi dairy producer released its half year results in the midst of market turmoil. Shares in Synlait have fallen 30% in the current market maelstrom. The company has reported mixed results today with revenues up but profits down, which may put further pressure on the share price. 

a woman

Synlait's half year results 

Synlait reported a strong increase in revenue, which was up 19% to $559 million, driven by strong growth in infant formula sales and a lift in commodity prices. Sales of consumer packaged infant formula were up 22%, albeit at lower margins. Lower sales of infant base powders were reported due to China infant nutrition market consolidation. 

Earnings before interest tax depreciation and amortisation (EBITDA) of $67.6 million were recorded, in line with 1HFY19. Gross profit reduced marginally during the half, falling to $82.9 million from $85.9 million in 1HFY19 due to an increase in overhead costs. Overhead costs increased by 27% during the half driven by increased employee costs, the establishment of a China sales office, and an increase in Synlait Pokeno overheads. 

Net profit after tax (NPAT) declined 30% to $26.2 million due to higher depreciation and interest costs attributable to growth investments. Earnings per share fell to 14.61 cents from 20.82 cents in 1HFY19. 

Full year guidance is for NPAT of $70–$85 million, with core earnings remaining sound. Cost reduction is a focus moving forward with more than $10 million in operating costs deferred and rephased during FY20.    

Debt 

Net debt increased substantially during the half to $447.4 million, up $159.7 million. $220 million in capital expenditure was incurred during the half to create a second infant-capable manufacturing facility in Pokeno and an advanced dairy liquid packaging facility at Dunsandel. 

Additional debt will be drawn down to facilitate the acquisition of Dairyworks and farmlands adjacent to the Dunsandel facility. Synlait forecasts that it will remain within banking covenant leverage ratios, despite high capital expenditure and lower profit guidance. 

The acquisition of Dairyworks by Synlait is due to settle on 1 April 2020 at a price of $112 million. Synlait is forecasting the acquisition will provide a sustainable earnings stream of approximately $15–20 million in EBITDA. This will emerge over the next 2 years as growth momentum and synergies are realised. 

Coronavirus update 

Synlait reports the coronavirus has had no significant operational impact to date. The dairy company is seeing some pressure on its broader supply chain, particularly container space availability and shipping schedules. This is being managed through strong relationships with raw material suppliers and logistics partners, which are being leveraged to gain forward views of export capacity. 

Motley Fool contributor Kate O'Brien has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the week for investors this Friday.

Read more »

Woman thinking in a supermarket.
Dividend Investing

Coles stock vs Woolworths shares: Who had the better dividend this week?

Let's check the receipts on Coles and Woolies this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

ASX board.
ASX Share Market News

Why the ASX 200 is pushing higher as rate hike fears grow

Tech stocks are leading the market rebound today.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »